Sabrina L. Zeller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sabrina L. Zeller has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Eris Spirollari
New York Medical College, Valhalla, USA
3 shared publications - Simon Hanft
Westchester Medical Center, Valhalla, NY
3 shared publications - Chirag D. Gandhi
Department of Neurosurgery, WestChester Medical Center, Valhalla, New York, USA
2 shared publications - Meena Jhanwar-Uniyal
Department of Neurosurgery, New York Medical College/Westchester Medical Center, Valhalla, NY, U.S.A.
2 shared publications Sauson Soldozy
Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, New York, USA
2 shared publications- Aarti Kishore Jain
New York Medical College
1 shared publication
Latest Publications
- 2 September 2026
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (6) , 1513-1521
The History of Neurosurgery at New York Medical College and Westchester Medical Center
The history of the Department of Neurosurgery at the New York Medical College (NYMC) began in New York City in the early 20th century. The purpose of this manuscript is to educate on the history of neurosurgery at NYMC and Westchester Medical Center (WMC) from its early beginnings to its current state as a leader of neurosurgery in the region. Led by notable neurosurgeons, such as Thomas Hoen and Isadore Tarlov, the department provided critical neurosurgical treatments to patients at the Flower-Fifth Avenue Hospital (now known as the Terence Cardinal Cooke Health Care Center) and Metropolitan Hospital and was home to research advancements in peripheral nerve repair and spinal cord pathology. The department made the transition to WMC in the 1970s under the direction of Alan Rothballer, and a residency program was instituted by Samuel Kasoff and Richard Rovit in 1991. In 2020, Chirag Gandhi became chair and established fellowships in endovascular neurosurgery and neurocritical care, expanding opportunities for education. Building on this rich tradition, the NYMC/WMC Department of Neurosurgery continues to provide high-quality neurosurgical care while emphasizing resident education and research.
- 2 September 2026
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (6) , 1513-1521
The History of Neurosurgery at New York Medical College and Westchester Medical Center
The history of the Department of Neurosurgery at the New York Medical College (NYMC) began in New York City in the early 20th century. The purpose of this manuscript is to educate on the history of neurosurgery at NYMC and Westchester Medical Center (WMC) from its early beginnings to its current state as a leader of neurosurgery in the region. Led by notable neurosurgeons, such as Thomas Hoen and Isadore Tarlov, the department provided critical neurosurgical treatments to patients at the Flower-Fifth Avenue Hospital (now known as the Terence Cardinal Cooke Health Care Center) and Metropolitan Hospital and was home to research advancements in peripheral nerve repair and spinal cord pathology. The department made the transition to WMC in the 1970s under the direction of Alan Rothballer, and a residency program was instituted by Samuel Kasoff and Richard Rovit in 1991. In 2020, Chirag Gandhi became chair and established fellowships in endovascular neurosurgery and neurocritical care, expanding opportunities for education. Building on this rich tradition, the NYMC/WMC Department of Neurosurgery continues to provide high-quality neurosurgical care while emphasizing resident education and research.
- 11 September 2025
- Published by Springer Nature in Spine Deformity
- Vol. 14 (1) , 199-204
Bilateral anterior lumbar vertebral body tethering: a feasibility cohort study
Purpose Anterior vertebral body tethering (VBT) is a viable option for children with idiopathic scoliosis. Treating double major curves with bilateral VBT may allow patients to avoid spinal fusion while improving the coronal Cobb angle. Methods A single center retrospective study was conducted to identify all patients who underwent bilateral VBT (lowest instrumented vertebra L3 or 4) with minimum 2-year follow-up. Clinical and radiographic parameters were collected, including complications and reoperations. Statistical analysis was performed utilizing Students’ t-test. Results Seventy-three patients (67 female, 91.8%) underwent bilateral VBT with mean follow-up of 4.2 ± 1.5 years. Preoperatively, all patients were skeletally immature (age 12.7 ± 1.2 years with a Sanders score of 3.3 ± 0.8 and Risser grade of 0.6 ± 0.8). The preoperative lumbar Cobb angle was 51.1° ± 7.9° which corrected to 20.7° ± 11.3° at most recent follow-up (p < 0.01) and the thoracic Cobb angle measured 52.3° ± 9.0° which corrected to 27.0° ± 11.3° (p < 0.01) at most recent follow-up. At latest follow-up, 51/73 (69.9%) had a thoracic Cobb angle <30°, 59/73 patients (80.8%) had a lumbar Cobb angle <30°, and 47/73 (64.4%) had both thoracic and lumbar Cobb angles <30°. 15 patients (20.5%) underwent 17 reoperations with overcorrection being the most common indication (8/17, 47.1%). Broken tethers led to reoperation in 3/17 instances (17.6%). Five patients (6.8%) eventually required posterior spinal fusion. Conclusions Bilateral VBT is a safe procedure and may be a viable option for patients with double curves, with the majority of curves measuring <30° at most recent follow-up. Surgeons can use these data to help patients and parents make informed decisions regarding treatment options.
- 11 September 2025
- Published by Springer Nature in Spine Deformity
- Vol. 14 (1) , 199-204
Bilateral anterior lumbar vertebral body tethering: a feasibility cohort study
Purpose Anterior vertebral body tethering (VBT) is a viable option for children with idiopathic scoliosis. Treating double major curves with bilateral VBT may allow patients to avoid spinal fusion while improving the coronal Cobb angle. Methods A single center retrospective study was conducted to identify all patients who underwent bilateral VBT (lowest instrumented vertebra L3 or 4) with minimum 2-year follow-up. Clinical and radiographic parameters were collected, including complications and reoperations. Statistical analysis was performed utilizing Students’ t-test. Results Seventy-three patients (67 female, 91.8%) underwent bilateral VBT with mean follow-up of 4.2 ± 1.5 years. Preoperatively, all patients were skeletally immature (age 12.7 ± 1.2 years with a Sanders score of 3.3 ± 0.8 and Risser grade of 0.6 ± 0.8). The preoperative lumbar Cobb angle was 51.1° ± 7.9° which corrected to 20.7° ± 11.3° at most recent follow-up (p < 0.01) and the thoracic Cobb angle measured 52.3° ± 9.0° which corrected to 27.0° ± 11.3° (p < 0.01) at most recent follow-up. At latest follow-up, 51/73 (69.9%) had a thoracic Cobb angle <30°, 59/73 patients (80.8%) had a lumbar Cobb angle <30°, and 47/73 (64.4%) had both thoracic and lumbar Cobb angles <30°. 15 patients (20.5%) underwent 17 reoperations with overcorrection being the most common indication (8/17, 47.1%). Broken tethers led to reoperation in 3/17 instances (17.6%). Five patients (6.8%) eventually required posterior spinal fusion. Conclusions Bilateral VBT is a safe procedure and may be a viable option for patients with double curves, with the majority of curves measuring <30° at most recent follow-up. Surgeons can use these data to help patients and parents make informed decisions regarding treatment options.
- 25 June 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 256, 109024
Uninsured status is associated with worse outcomes in a cohort of pediatric patients with traumatic brain injury
- 25 June 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 256, 109024
Uninsured status is associated with worse outcomes in a cohort of pediatric patients with traumatic brain injury
- Open Access
- 11 April 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 129
Utility of ultrasound in the diagnosis and management of a radial nerve perineurioma in a pediatric patient
Background: Intraneural perineuriomas are tumors originating from the perineurial cells surrounding nerve sheath fascicles. Intraneural perineuriomas represent about 1% of peripheral nerve tumors and are often misdiagnosed due to their rarity. In this case, we report a pediatric patient with a radial nerve perineurioma, in which ultrasound played a key role in diagnosis. Case Description: We present the case of a 4-year-old male with over 6 months of progressive left upper extremity weakness found to have chronic left radial neuropathy distal to the triceps branch of the radial nerve on electromyography/nerve conduction study. Ultrasound showed a well-defined fusiform hypoechoic mass of approximately 1.5 × 0.5 × 0.8 cm, with the radial nerve noted to enter and exit the mass. Magnetic resonance imaging (MRI) did not encompass the pathology. The mass was excised with small margins, and pathology was consistent with perineurioma. The resultant 3 cm gap was repaired through nerve grafting. Surveillance MRI showed no recurrence of the perineurioma over time. Conclusion: Ultrasound served as a necessary adjunct in the workup of upper extremity weakness despite negative MRI findings. This imaging modality should be considered if there is high clinical suspicion of a peripheral nerve lesion.
- 11 April 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 129
Open AccessUtility of ultrasound in the diagnosis and management of a radial nerve perineurioma in a pediatric patient
Background: Intraneural perineuriomas are tumors originating from the perineurial cells surrounding nerve sheath fascicles. Intraneural perineuriomas represent about 1% of peripheral nerve tumors and are often misdiagnosed due to their rarity. In this case, we report a pediatric patient with a radial nerve perineurioma, in which ultrasound played a key role in diagnosis. Case Description: We present the case of a 4-year-old male with over 6 months of progressive left upper extremity weakness found to have chronic left radial neuropathy distal to the triceps branch of the radial nerve on electromyography/nerve conduction study. Ultrasound showed a well-defined fusiform hypoechoic mass of approximately 1.5 × 0.5 × 0.8 cm, with the radial nerve noted to enter and exit the mass. Magnetic resonance imaging (MRI) did not encompass the pathology. The mass was excised with small margins, and pathology was consistent with perineurioma. The resultant 3 cm gap was repaired through nerve grafting. Surveillance MRI showed no recurrence of the perineurioma over time. Conclusion: Ultrasound served as a necessary adjunct in the workup of upper extremity weakness despite negative MRI findings. This imaging modality should be considered if there is high clinical suspicion of a peripheral nerve lesion.
- Open Access
- 13 March 2025
- Published by IntechOpen
Advanced Imaging and Augmented Reality in Neurosurgery: Bridging Innovation and Precision
The evolution of advanced imaging technologies has profoundly impacted neurosurgery, enabling greater precision, safety, and improved outcomes in complex procedures. This chapter provides a comprehensive overview of key imaging modalities such as MRI, CT, fMRI, DTI, and iMRI, emphasizing their roles in neurosurgical planning, navigation, and real-time monitoring. Building on these technologies, the advent of augmented reality (AR) has introduced transformative tools that overlay digital information onto the surgical field, allowing neurosurgeons to visualize critical anatomical structures with unprecedented clarity. The integration of AR with imaging systems enhances preoperative planning, intraoperative navigation, and postoperative assessment across various neurosurgical domains, from tumor resections to minimally invasive spinal surgeries. Despite these advancements, the chapter also examines technical and practical challenges, including AR system latency, high implementation costs, and training demands. Ethical and regulatory considerations are also discussed, underscoring the need for stringent data security and alignment with healthcare regulations. The chapter concludes by exploring the potential of integrating AI-driven AR and emerging imaging modalities, highlighting the continuous innovations shaping the future of neurosurgical precision, safety, and patient care.
- 13 March 2025
- Published by IntechOpen
Open AccessAdvanced Imaging and Augmented Reality in Neurosurgery: Bridging Innovation and Precision
The evolution of advanced imaging technologies has profoundly impacted neurosurgery, enabling greater precision, safety, and improved outcomes in complex procedures. This chapter provides a comprehensive overview of key imaging modalities such as MRI, CT, fMRI, DTI, and iMRI, emphasizing their roles in neurosurgical planning, navigation, and real-time monitoring. Building on these technologies, the advent of augmented reality (AR) has introduced transformative tools that overlay digital information onto the surgical field, allowing neurosurgeons to visualize critical anatomical structures with unprecedented clarity. The integration of AR with imaging systems enhances preoperative planning, intraoperative navigation, and postoperative assessment across various neurosurgical domains, from tumor resections to minimally invasive spinal surgeries. Despite these advancements, the chapter also examines technical and practical challenges, including AR system latency, high implementation costs, and training demands. Ethical and regulatory considerations are also discussed, underscoring the need for stringent data security and alignment with healthcare regulations. The chapter concludes by exploring the potential of integrating AI-driven AR and emerging imaging modalities, highlighting the continuous innovations shaping the future of neurosurgical precision, safety, and patient care.
- Open Access
- 13 December 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 460
Safety of emergency endoscopic endonasal surgery in COVID-positive patients with hemorrhagic complications of pituitary region tumors: A case report and review of the literature
Background: Pituitary apoplexy (PA) is a rare, life-threatening clinical syndrome that occurs in response to acute ischemic infarction or hemorrhage of a pituitary adenoma. We report two cases of sudden neurologic and visual decline in patients with pituitary region masses in coronavirus disease (COVID)-positive patients with a focus on potential pathophysiological mechanisms and a safe approach to treatment. Case Description: Case one is a 58-year-old male presenting with sudden-onset headache and visual disturbance. He was febrile and tested positive for COVID-19. Magnetic resonance imaging (MRI) revealed a large sellarsuprasellar mass with intratumoral hemorrhagic components. He underwent endoscopic endonasal resection with subsequent improvement in vision and oculomotor function. Pathology was consistent with hemorrhagic pituitary adenoma. Case two is a 15-year-old male presenting with sudden-onset severe headache and acute visual loss. He also tested positive for COVID-19. MRI revealed a sellar-suprasellar mass with a regional mass effect. He underwent endoscopic endonasal resection with improvement in vision over time. Pathology was consistent with craniopharyngioma. There was no evidence of intraoperative COVID-19 transmission among members of the surgical team, who were monitored for 2 weeks after surgery. Conclusion: PA in the setting of severe acute respiratory syndrome coronavirus 2 infection should be considered in the differential diagnosis of a COVID-positive patient presenting with acute severe headache, visual loss, and/or ophthalmoplegia; we discuss proposed mechanisms related to inflammation, coagulability, and hypoxia. The absence of intraoperative COVID-19 transmission during transsphenoidal resection performed in an emergency setting suggests that the risk of exposure may be attenuated with safety precautions.
- 13 December 2024
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 15, 460
Open AccessSafety of emergency endoscopic endonasal surgery in COVID-positive patients with hemorrhagic complications of pituitary region tumors: A case report and review of the literature
Background: Pituitary apoplexy (PA) is a rare, life-threatening clinical syndrome that occurs in response to acute ischemic infarction or hemorrhage of a pituitary adenoma. We report two cases of sudden neurologic and visual decline in patients with pituitary region masses in coronavirus disease (COVID)-positive patients with a focus on potential pathophysiological mechanisms and a safe approach to treatment. Case Description: Case one is a 58-year-old male presenting with sudden-onset headache and visual disturbance. He was febrile and tested positive for COVID-19. Magnetic resonance imaging (MRI) revealed a large sellarsuprasellar mass with intratumoral hemorrhagic components. He underwent endoscopic endonasal resection with subsequent improvement in vision and oculomotor function. Pathology was consistent with hemorrhagic pituitary adenoma. Case two is a 15-year-old male presenting with sudden-onset severe headache and acute visual loss. He also tested positive for COVID-19. MRI revealed a sellar-suprasellar mass with a regional mass effect. He underwent endoscopic endonasal resection with improvement in vision over time. Pathology was consistent with craniopharyngioma. There was no evidence of intraoperative COVID-19 transmission among members of the surgical team, who were monitored for 2 weeks after surgery. Conclusion: PA in the setting of severe acute respiratory syndrome coronavirus 2 infection should be considered in the differential diagnosis of a COVID-positive patient presenting with acute severe headache, visual loss, and/or ophthalmoplegia; we discuss proposed mechanisms related to inflammation, coagulability, and hypoxia. The absence of intraoperative COVID-19 transmission during transsphenoidal resection performed in an emergency setting suggests that the risk of exposure may be attenuated with safety precautions.
- 9 September 2024
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (4) , 794-801
Central Nervous System Infections in Patients With Ventriculoperitoneal Shunts Admitted for Primary Abdominal Infections: A US Nationwide Cohort Analysis
BACKGROUND AND OBJECTIVES: Although ventriculoperitoneal (VP) shunts are a common treatment for hydrocephalus, there are complication risks including infections. Late complications such as ventriculitis from ascending abdominal infections can have severe consequences. However, the incidence of central nervous system (CNS) infections in VP shunt patients with abdominal infections is not well understood. We aimed to determine the incidence of CNS infections in VP shunt patients admitted with abdominal infections. METHODS: Using the National Inpatient Sample, we studied patients from 2016 to 2019 to determine the incidence of CNS infections in VP shunt patients admitted with abdominal infections. Results were compared with VP shunt patients admitted for primary pneumonia. RESULTS: Among 725 VP shunt patients presenting with abdominal infections, 20 (2.8%) had CNS infections. Chronic obstructive pulmonary disease, hypertension, older age, and a smoking history were more common in patients with CNS infections and primary abdominal infection (P < .05). Patients who developed CNS infection had a significantly higher likelihood of both blood transfusion and coma but a lower likelihood of seizures. VP shunt patients with CNS infections were more likely to undergo shunt removal (odds ratio [OR] = 23.167, P < .001). 4.1% of VP shunt patients with primary abdominal infections died during admission. In a population of primary abdominal infection and pneumonia patients with VP shunts, a multivariate logistic regression analysis controlling for age, sex, and comorbidities identified abdominal infection as an independent risk factor for both CNS infection (OR = 51.208, P < .001) and inpatient death (OR = 3.417, P < .001). Among 6620 VP shunt patients admitted with primary pneumonia, only 5 (0.1%) had CNS infection compared with 20 (2.8%) in those with a primary abdominal infection (OR = 37.532, P < .001), and mortality was 1.6% vs 4.1% for those with a primary abdominal infection (P < .05). CONCLUSION: CNS infections in VP-shunted patients with abdominal infections are relatively rare but may lead to increased risks of death and other serious adverse outcomes.
- 9 September 2024
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (4) , 794-801
Central Nervous System Infections in Patients With Ventriculoperitoneal Shunts Admitted for Primary Abdominal Infections: A US Nationwide Cohort Analysis
BACKGROUND AND OBJECTIVES: Although ventriculoperitoneal (VP) shunts are a common treatment for hydrocephalus, there are complication risks including infections. Late complications such as ventriculitis from ascending abdominal infections can have severe consequences. However, the incidence of central nervous system (CNS) infections in VP shunt patients with abdominal infections is not well understood. We aimed to determine the incidence of CNS infections in VP shunt patients admitted with abdominal infections. METHODS: Using the National Inpatient Sample, we studied patients from 2016 to 2019 to determine the incidence of CNS infections in VP shunt patients admitted with abdominal infections. Results were compared with VP shunt patients admitted for primary pneumonia. RESULTS: Among 725 VP shunt patients presenting with abdominal infections, 20 (2.8%) had CNS infections. Chronic obstructive pulmonary disease, hypertension, older age, and a smoking history were more common in patients with CNS infections and primary abdominal infection (P < .05). Patients who developed CNS infection had a significantly higher likelihood of both blood transfusion and coma but a lower likelihood of seizures. VP shunt patients with CNS infections were more likely to undergo shunt removal (odds ratio [OR] = 23.167, P < .001). 4.1% of VP shunt patients with primary abdominal infections died during admission. In a population of primary abdominal infection and pneumonia patients with VP shunts, a multivariate logistic regression analysis controlling for age, sex, and comorbidities identified abdominal infection as an independent risk factor for both CNS infection (OR = 51.208, P < .001) and inpatient death (OR = 3.417, P < .001). Among 6620 VP shunt patients admitted with primary pneumonia, only 5 (0.1%) had CNS infection compared with 20 (2.8%) in those with a primary abdominal infection (OR = 37.532, P < .001), and mortality was 1.6% vs 4.1% for those with a primary abdominal infection (P < .05). CONCLUSION: CNS infections in VP-shunted patients with abdominal infections are relatively rare but may lead to increased risks of death and other serious adverse outcomes.
- 10 June 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (9) , 2769-2774
Application of Brain Injury Guidelines at a Pediatric Level 1 Trauma Center predicts reliability, safety, and improved resource utilization
Purpose Brain Injury Guidelines (BIG) have been established to guide management related to TBI in adults. Here, BIG criteria were applied to pediatric TBI patients to evaluate reliability, safety, and resource utilization. Methods A retrospective study was performed on all pediatric TBI patients aged 18 years or younger from January 2012 to July 2023 at a Level 1 Pediatric Trauma Center. The severity of TBI (BIG 1/2/3) was rated by review of initial cranial imaging by two independent observers. Inter-observer reliability was assessed. Predictions based on BIG criteria regarding repeat cranial imaging, ICU admission, and neurosurgical consultation were compared with observations from the cohort. Outcome data was collected, including neurosurgical intervention and mortality rate. Results Three hundred fifty-nine patients were included with mean age of 5.3 years. Injury severity included 44 BIG 1 (12.2%), 170 BIG 2 (47.4%), and 145 BIG 3 injuries (40.4%). Inter-rater reliability was 96.4%. Neurosurgical consultation was obtained in all patients, though only predicted by guidelines in 40.4%. Repeat imaging was obtained in 166 BIG 1/2 patients, with an average of 1.3 CT scans and 0.8 MRIs/rapid MRIs per patient. ICU was utilized in 104 (77.6%) patients not recommended per BIG criteria. Ultimately, 37 patients, all BIG 3, required neurosurgical intervention; no neurosurgical interventions were required in those classified as BIG 1/2. Conclusions BIG criteria can be applied to pediatric TBI with high inter-observer reliability and without formal neurosurgical training. Retrospective application of BIG predicted fewer imaging studies, ICU admissions, and neurosurgical consults without overlooking patients requiring neurosurgical intervention.
- 10 June 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (9) , 2769-2774
Application of Brain Injury Guidelines at a Pediatric Level 1 Trauma Center predicts reliability, safety, and improved resource utilization
Purpose Brain Injury Guidelines (BIG) have been established to guide management related to TBI in adults. Here, BIG criteria were applied to pediatric TBI patients to evaluate reliability, safety, and resource utilization. Methods A retrospective study was performed on all pediatric TBI patients aged 18 years or younger from January 2012 to July 2023 at a Level 1 Pediatric Trauma Center. The severity of TBI (BIG 1/2/3) was rated by review of initial cranial imaging by two independent observers. Inter-observer reliability was assessed. Predictions based on BIG criteria regarding repeat cranial imaging, ICU admission, and neurosurgical consultation were compared with observations from the cohort. Outcome data was collected, including neurosurgical intervention and mortality rate. Results Three hundred fifty-nine patients were included with mean age of 5.3 years. Injury severity included 44 BIG 1 (12.2%), 170 BIG 2 (47.4%), and 145 BIG 3 injuries (40.4%). Inter-rater reliability was 96.4%. Neurosurgical consultation was obtained in all patients, though only predicted by guidelines in 40.4%. Repeat imaging was obtained in 166 BIG 1/2 patients, with an average of 1.3 CT scans and 0.8 MRIs/rapid MRIs per patient. ICU was utilized in 104 (77.6%) patients not recommended per BIG criteria. Ultimately, 37 patients, all BIG 3, required neurosurgical intervention; no neurosurgical interventions were required in those classified as BIG 1/2. Conclusions BIG criteria can be applied to pediatric TBI with high inter-observer reliability and without formal neurosurgical training. Retrospective application of BIG predicted fewer imaging studies, ICU admissions, and neurosurgical consults without overlooking patients requiring neurosurgical intervention.
- 30 April 2024
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 27 (6) , 675-680
Evaluation of the Safety of Liberalized Systolic Blood Pressure Goals in the Postoperative Period After Intracranial Tumor Resection
BACKGROUND AND OBJECTIVES: Postoperative intracranial hemorrhage (POH) is a serious neurosurgical complication occurring in approximately 1.4% of patients after intracranial tumor resection. The convention across the United States is to maintain an immediate postoperative systolic blood pressure (SBP) of < 140 mm Hg to minimize this risk; however, this SBP goal lacks support in the literature despite widespread adoption. This study aims to investigate the safety of SBP liberalization to 160 mm Hg in the immediate postoperative setting after intracranial tumor resection. METHODS: A retrospective review was conducted on consecutive patients, aged 18 to 75 years, undergoing craniotomy for intracranial tumor resection from October 2020 until June 2023. Data were gathered from the electronic medical record per Institutional Review Board guidelines regarding demographics, operative details, perioperative vital signs, resource utilization, and complications. Pharmaceutical prices and insurance charges were approximated from costs provided by the institution's pharmacy. POH was defined as symptomatic hemorrhage within 48 hours requiring intervention. RESULTS: The study included 147 patients, with 104 in the liberalized cohort (SBP P = .23). Intensive care unit and hospital length of stay were not significantly different between groups. The liberalized group used $81.88 ± $280.19 (95% CI $53.01-$110.75) on as-needed antihypertensive medications vs $108.39 ± $215.91 (95% CI $75.96-$140.82) in the standard (P = .29), with significantly lower labetalol (P = .04). There was no POH in either cohort. CONCLUSION: Liberalization of SBP goals to <160 mm Hg appears safe in the immediate postoperative period after craniotomy for tumor resection without an increased POH risk. Liberalized SBP parameters may allow reduced antihypertensive medication usage, thereby avoiding excess hospital cost and medication side effects.
- 30 April 2024
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 27 (6) , 675-680
Evaluation of the Safety of Liberalized Systolic Blood Pressure Goals in the Postoperative Period After Intracranial Tumor Resection
BACKGROUND AND OBJECTIVES: Postoperative intracranial hemorrhage (POH) is a serious neurosurgical complication occurring in approximately 1.4% of patients after intracranial tumor resection. The convention across the United States is to maintain an immediate postoperative systolic blood pressure (SBP) of < 140 mm Hg to minimize this risk; however, this SBP goal lacks support in the literature despite widespread adoption. This study aims to investigate the safety of SBP liberalization to 160 mm Hg in the immediate postoperative setting after intracranial tumor resection. METHODS: A retrospective review was conducted on consecutive patients, aged 18 to 75 years, undergoing craniotomy for intracranial tumor resection from October 2020 until June 2023. Data were gathered from the electronic medical record per Institutional Review Board guidelines regarding demographics, operative details, perioperative vital signs, resource utilization, and complications. Pharmaceutical prices and insurance charges were approximated from costs provided by the institution's pharmacy. POH was defined as symptomatic hemorrhage within 48 hours requiring intervention. RESULTS: The study included 147 patients, with 104 in the liberalized cohort (SBP P = .23). Intensive care unit and hospital length of stay were not significantly different between groups. The liberalized group used $81.88 ± $280.19 (95% CI $53.01-$110.75) on as-needed antihypertensive medications vs $108.39 ± $215.91 (95% CI $75.96-$140.82) in the standard (P = .29), with significantly lower labetalol (P = .04). There was no POH in either cohort. CONCLUSION: Liberalization of SBP goals to <160 mm Hg appears safe in the immediate postoperative period after craniotomy for tumor resection without an increased POH risk. Liberalized SBP parameters may allow reduced antihypertensive medication usage, thereby avoiding excess hospital cost and medication side effects.
- Open Access
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets
The mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that functions via its discrete binding partners to form two multiprotein complexes, mTOR complex 1 and 2 (mTORC1 and mTORC2). Rapamycin-sensitive mTORC1, which regulates protein synthesis and cell growth, is tightly controlled by PI3K/Akt and is nutrient-/growth factor-sensitive. In the brain, mTORC1 is also sensitive to neurotransmitter signaling. mTORC2, which is modulated by growth factor signaling, is associated with ribosomes and is insensitive to rapamycin. mTOR regulates stem cell and cancer stem cell characteristics. Aberrant Akt/mTOR activation is involved in multistep tumorigenesis in a variety of cancers, thereby suggesting that the inhibition of mTOR may have therapeutic potential. Rapamycin and its analogues, known as rapalogues, suppress mTOR activity through an allosteric mechanism that only suppresses mTORC1, albeit incompletely. ATP-catalytic binding site inhibitors are designed to inhibit both complexes. This review describes the regulation of mTOR and the targeting of its complexes in the treatment of cancers, such as glioblastoma, and their stem cells.
Open AccessDiscrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets
The mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that functions via its discrete binding partners to form two multiprotein complexes, mTOR complex 1 and 2 (mTORC1 and mTORC2). Rapamycin-sensitive mTORC1, which regulates protein synthesis and cell growth, is tightly controlled by PI3K/Akt and is nutrient-/growth factor-sensitive. In the brain, mTORC1 is also sensitive to neurotransmitter signaling. mTORC2, which is modulated by growth factor signaling, is associated with ribosomes and is insensitive to rapamycin. mTOR regulates stem cell and cancer stem cell characteristics. Aberrant Akt/mTOR activation is involved in multistep tumorigenesis in a variety of cancers, thereby suggesting that the inhibition of mTOR may have therapeutic potential. Rapamycin and its analogues, known as rapalogues, suppress mTOR activity through an allosteric mechanism that only suppresses mTORC1, albeit incompletely. ATP-catalytic binding site inhibitors are designed to inhibit both complexes. This review describes the regulation of mTOR and the targeting of its complexes in the treatment of cancers, such as glioblastoma, and their stem cells.